Francesca Barone is Chief Scientific Officer of Candel Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Nov 23 | CADL Candel Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.9 | 19,748 | 17.77 k | 186,657 |
26 Nov 23 | CADL Candel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 112,790 | 0.00 | 206,405 |
28 Apr 23 | CADL Candel Therapeutics | Stock Option (Right to Biuy) Common Stock | Grant | Acquire A | No | No | 1.29 | 90,000 | 116.10 k | 90,000 |
8 Dec 22 | CADL Candel Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.61 | 1,238 | 1.99 k | 2,738 |
28 Nov 22 | CADL Candel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 90,877 | 0.00 | 92,377 |